Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2130852442', 'doi': 'https://doi.org/10.1586/14737140.1.1.13', 'title': 'Temozolomide: a novel oral alkylating agent', 'display_name': 'Temozolomide: a novel oral alkylating agent', 'publication_year': 2001, 'publication_date': '2001-06-01', 'ids': {'openalex': 'https://openalex.org/W2130852442', 'doi': 'https://doi.org/10.1586/14737140.1.1.13', 'mag': '2130852442', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12113120'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1586/14737140.1.1.13', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S93370067', 'display_name': 'Expert Review of Anticancer Therapy', 'issn_l': '1473-7140', 'issn': ['1473-7140', '1744-8328'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5070212769', 'display_name': 'Sarah Danson', 'orcid': 'https://orcid.org/0000-0002-3593-2890'}, 'institutions': [{'id': 'https://openalex.org/I4210131968', 'display_name': 'The Christie Hospital', 'ror': 'https://ror.org/03nd63441', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210131968', 'https://openalex.org/I4210133995']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Sarah J Danson', 'raw_affiliation_strings': ['Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 9BX, UK. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 9BX, UK. [email protected]', 'institution_ids': ['https://openalex.org/I4210131968']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5051430596', 'display_name': 'Mark R. Middleton', 'orcid': 'https://orcid.org/0000-0003-0167-1685'}, 'institutions': [{'id': 'https://openalex.org/I4210131968', 'display_name': 'The Christie Hospital', 'ror': 'https://ror.org/03nd63441', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210131968', 'https://openalex.org/I4210133995']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Mark R Middleton', 'raw_affiliation_strings': ['Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 9BX, UK. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 9BX, UK. [email protected]', 'institution_ids': ['https://openalex.org/I4210131968']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.459, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 104, 'citation_normalized_percentile': {'value': 0.812687, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '1', 'issue': '1', 'first_page': '13', 'last_page': '19'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11600', 'display_name': 'Management of Brain Metastases in Cancer Patients', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11600', 'display_name': 'Management of Brain Metastases in Cancer Patients', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10129', 'display_name': 'Gliomas', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'DNA Topoisomerases: Structure, Function, and Inhibition', 'score': 0.9931, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/dacarbazine', 'display_name': 'Dacarbazine', 'score': 0.91982424}, {'id': 'https://openalex.org/keywords/temozolomide', 'display_name': 'Temozolomide', 'score': 0.602633}, {'id': 'https://openalex.org/keywords/active-metabolite', 'display_name': 'Active metabolite', 'score': 0.4396172}], 'concepts': [{'id': 'https://openalex.org/C2777389519', 'wikidata': 'https://www.wikidata.org/wiki/Q425088', 'display_name': 'Temozolomide', 'level': 3, 'score': 0.9788729}, {'id': 'https://openalex.org/C2780964509', 'wikidata': 'https://www.wikidata.org/wiki/Q416975', 'display_name': 'Dacarbazine', 'level': 3, 'score': 0.91982424}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8986876}, {'id': 'https://openalex.org/C2777658100', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Melanoma', 'level': 2, 'score': 0.58187836}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.53728914}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.5005977}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.47203007}, {'id': 'https://openalex.org/C114851261', 'wikidata': 'https://www.wikidata.org/wiki/Q12147416', 'display_name': 'Drug resistance', 'level': 2, 'score': 0.44209188}, {'id': 'https://openalex.org/C149151106', 'wikidata': 'https://www.wikidata.org/wiki/Q4677569', 'display_name': 'Active metabolite', 'level': 3, 'score': 0.4396172}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.4394445}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.4322211}, {'id': 'https://openalex.org/C2778227246', 'wikidata': 'https://www.wikidata.org/wiki/Q1365309', 'display_name': 'Glioma', 'level': 2, 'score': 0.42213798}, {'id': 'https://openalex.org/C2777477808', 'wikidata': 'https://www.wikidata.org/wiki/Q407595', 'display_name': 'Metabolite', 'level': 2, 'score': 0.37880957}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.33903348}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.2584563}, {'id': 'https://openalex.org/C89423630', 'wikidata': 'https://www.wikidata.org/wiki/Q7193', 'display_name': 'Microbiology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D018906', 'descriptor_name': 'Antineoplastic Agents, Alkylating', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D003606', 'descriptor_name': 'Dacarbazine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018906', 'descriptor_name': 'Antineoplastic Agents, Alkylating', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018906', 'descriptor_name': 'Antineoplastic Agents, Alkylating', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D001932', 'descriptor_name': 'Brain Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D001932', 'descriptor_name': 'Brain Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003606', 'descriptor_name': 'Dacarbazine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003606', 'descriptor_name': 'Dacarbazine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003606', 'descriptor_name': 'Dacarbazine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005910', 'descriptor_name': 'Glioma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005910', 'descriptor_name': 'Glioma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D000077204', 'descriptor_name': 'Temozolomide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1586/14737140.1.1.13', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S93370067', 'display_name': 'Expert Review of Anticancer Therapy', 'issn_l': '1473-7140', 'issn': ['1473-7140', '1744-8328'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12113120', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 37, 'referenced_works': ['https://openalex.org/W1777661785', 'https://openalex.org/W1806652950', 'https://openalex.org/W1813879195', 'https://openalex.org/W1835101589', 'https://openalex.org/W1861898234', 'https://openalex.org/W1872551000', 'https://openalex.org/W1879616740', 'https://openalex.org/W1917632054', 'https://openalex.org/W1943407880', 'https://openalex.org/W1950572133', 'https://openalex.org/W1966682923', 'https://openalex.org/W1967090290', 'https://openalex.org/W1967912888', 'https://openalex.org/W1971786465', 'https://openalex.org/W1972180573', 'https://openalex.org/W1977392502', 'https://openalex.org/W1990159395', 'https://openalex.org/W1990978695', 'https://openalex.org/W1993808515', 'https://openalex.org/W2033612622', 'https://openalex.org/W2036261627', 'https://openalex.org/W2041332808', 'https://openalex.org/W2043451385', 'https://openalex.org/W2053668604', 'https://openalex.org/W2079786467', 'https://openalex.org/W2080850099', 'https://openalex.org/W2082016897', 'https://openalex.org/W2088925558', 'https://openalex.org/W2095515836', 'https://openalex.org/W2101183874', 'https://openalex.org/W2129146015', 'https://openalex.org/W2129160559', 'https://openalex.org/W2167713837', 'https://openalex.org/W2264385870', 'https://openalex.org/W2899476007', 'https://openalex.org/W4285719527', 'https://openalex.org/W74630874'], 'related_works': ['https://openalex.org/W749587570', 'https://openalex.org/W4309356005', 'https://openalex.org/W4295758394', 'https://openalex.org/W3202735287', 'https://openalex.org/W3137934273', 'https://openalex.org/W2401663852', 'https://openalex.org/W2399057994', 'https://openalex.org/W2141845144', 'https://openalex.org/W2062246677', 'https://openalex.org/W2023487034'], 'abstract_inverted_index': {'Temozolomide': [0], 'is': [1, 39], 'an': [2, 30], 'imidazotetrazine': [3], 'with': [4, 74], 'a': [5, 44], 'mechanism': [6], 'of': [7, 82, 87, 96], 'action': [8], 'and': [9, 33, 62, 86], 'efficacy': [10], 'similar': [11], 'to': [12, 29, 51, 89], 'dacarbazine': [13], '(DTIC).': [14], 'However,': [15], 'it': [16, 22, 43], 'differs': [17], 'from': [18], 'DTIC': [19], 'in': [20, 58, 70], 'that': [21], 'can': [23], 'be': [24], 'taken': [25], 'orally,': [26], 'degrades': [27], 'spontaneously': [28], 'active': [31], 'metabolite': [32], 'penetrates': [34], 'the': [35, 94], 'blood–brain': [36], 'barrier.': [37], 'It': [38], 'well': [40], 'tolerated,': [41], 'making': [42], 'suitable': [45], 'candidate': [46], 'for': [47], 'combination': [48], 'chemotherapy.': [49], 'Trials': [50], 'date': [52], 'have': [53], 'focussed': [54], 'on': [55], 'its': [56], 'activity': [57], 'advanced': [59], 'metastatic': [60], 'melanoma': [61], 'high-grade': [63], 'malignant': [64], 'glioma.': [65], 'Investigations': [66], 'into': [67], 'other': [68], 'indications,': [69], 'particular': [71], 'solid': [72], 'tumors': [73], 'central': [75], 'nervous': [76], 'system': [77], 'metastases,': [78], 'are': [79], 'ongoing.': [80], 'Studies': [81], 'new': [83], 'drug': [84], 'schedules': [85], 'drugs': [88], 'ameliorate': [90], 'temozolomide': [91], 'resistance': [92], 'offer': [93], 'prospect': [95], 'increased': [97], 'efficacy.': [98]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2130852442', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 4}, {'year': 2022, 'cited_by_count': 9}, {'year': 2021, 'cited_by_count': 7}, {'year': 2020, 'cited_by_count': 3}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 8}, {'year': 2015, 'cited_by_count': 7}, {'year': 2014, 'cited_by_count': 5}, {'year': 2013, 'cited_by_count': 5}, {'year': 2012, 'cited_by_count': 4}], 'updated_date': '2024-08-15T13:13:33.268151', 'created_date': '2016-06-24'}